Market Place
Sourcing Support
Dr Reddy`s Laboratories Receives Approval From Health Canada
29 Apr 2026 //
PRESS RELEASE
Dr Reddy`s Gets Nod To Roll Out Generic Oral Semaglutide Drug
16 Apr 2026 //
PRESS RELEASE
Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
06 Apr 2026 //
ECONOMICTIMES
USV Launches `Usema` To Address India`s Metabolic Health Burden
23 Mar 2026 //
EXPRESSPHARMA
Semaglutide Patent Expiry Slashes India`s Weight-Loss Drug Prices
25 Feb 2026 //
ECONOMICTIMES
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
Dr. Reddy’s Announces First-to-Market Launch of Olopatadine HCl
14 Jan 2026 //
PRESS RELEASE
HC OKs Dr. Reddy`s Semaglutide Exports, Bars Sales in India
03 Dec 2025 //
ECONOMICTIMES
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Dr. Reddy`s, Hetero Secure Support to Produce Generic Yeztugo
24 Sep 2025 //
FIERCE PHARMA
Dr Reddy`s Launch Linaclotide for Chronic Constipation
27 Aug 2025 //
PRESS RELEASE
Extrovis & Dr Reddy’s launch Generic Fluorouracil Cream
21 Aug 2025 //
PRESS RELEASE
Tentative Approval for Generic Lumateperone capsules
05 Aug 2025 //
PRESS RELEASE
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
Pharma Companies Rush to Develop Weight-loss Drug Semaglutide
12 Apr 2025 //
ECONOMICTIMES
Senores Pharma Launches Ivermectin Tablets In US With Dr. Reddy’s
26 Nov 2024 //
PRESS RELEASE
Dr Reddy`s sign voluntary licenses with Gilead for HIV drug
02 Oct 2024 //
PRESS RELEASE
Dr Reddy`s enters trade generics with new division
24 Jun 2023 //
ECONOMIC TIMES
Dr. Reddy`s enters the trade generics business in India
23 Jun 2023 //
INDIANPHARMAPOST
Dr Reddy`s Labs launches generic injection in US
21 Apr 2023 //
ECONOMIC TIMES
Dr Reddy`s to acquire Mayne Pharma US generic portfolio for $115 million
27 Feb 2023 //
ECONOMIC TIMES
Dr. Reddy`s Announces the Launch of Valsartan Tablets, USP in the U.S. Market
09 Dec 2021 //
BUSINESSWIRE
Prestige, Dr. Reddy’s partner to commercialize trastuzumab biosimilar
08 Dec 2021 //
BUSINESSWIRE
Dr Reddys Labs launches Tecfidera generic in US market
28 Sep 2020 //
BUSINESS STANDARD
AbbVie Sues To Block Dr. Reddy`s Generic Leukemia Drug
27 Jul 2020 //
LAW360
Dr Reddy’s Labs launches generic Ocaliva in India
21 May 2020 //
PHARMABIZ
Safeguarding And Streamlining Pharma Supply Chain: Time For Certified Drugs
08 May 2020 //
FORBES
Dr. Reddy`s Lab Announces the First Generic Launch of Naproxen & Esomeprazole Mg
27 Feb 2020 //
BUSINESSWIRE
Dr Reddy`s launches generic hypotensive injection in US
01 Jan 2020 //
ECONOMIC TIMES
China Begins Import of Indian Generic Medicines Amid Trade War With US
27 Sep 2019 //
SPUTNIKNEWS
Dr. Reddy`s Labs launches generic Zyban in US market
05 Sep 2019 //
PHARMABIZ
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
03 Sep 2019 //
CNBC
Dr Reddy`s launches generic oral anti-epileptic drug in US
21 Aug 2019 //
ECONOMICTIMES
FDA greenlights nine Lyrica generics
25 Jul 2019 //
IN-PHARMATECHNOLOGIST
Dr Reddy`s launches generic testosterone gel in US market
06 May 2019 //
ECONOMIC TIMES
Old guard` generics players yield U.S. scripts lead
18 Apr 2019 //
FIERCE PHARMA
Indivior loses U.S. district court battle, copycat launches imminent
12 Feb 2019 //
REUTERS
Indivior faces huge loss as Suboxone court loss puts generics on tap
06 Feb 2019 //
FIERCE PHARMA
Dr. Reddy`s Appoints Marc Kikuchi to Lead Its Generics Business in NA
04 Feb 2019 //
BUSINESSWIRE
Dr Reddy`s launches injection for anesthesia and sedation in US market
24 Jan 2019 //
BUSINESS STANDARD
Indivior wins fresh hold on Dr. Reddy`s Suboxone copy
12 Dec 2018 //
REUTERS
NEXIUM (esomeprazole magnesium) : Dr. Reddy’s Labs vs. AstraZeneca
24 Nov 2018 //
PATENT LITIGATION
Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical
24 Nov 2018 //
PATENT LITIGATION
Dr Reddy`s victory in US patent case for opioid treatment film boosts generic drug makers
23 Nov 2018 //
INTERNATIONAL BUSINESS
Yonsa (Abiraterone Acetate) : Sun Pharmaceutical vs. Teva Pharmaceuticals
19 Oct 2018 //
PATENT LITIGATION
Teva to hold Indivior generic drug launch pending U.S. ruling
11 Sep 2018 //
REUTERS
Vascepa ( Ethyl eicosapentaenoic acid ) : Amarin Pharma v. Dr. Reddy`s Labs
27 Aug 2018 //
PATENT LITIGATION
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
31 Jul 2018 //
BUSINESS STANDARD
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017
09 Jul 2018 //
RAPS
Indivior seeks injunction to block Dr. Reddy’s generic launch in US
21 Jun 2018 //
IN PHARMATECHNOLOGIST
Temporary restraining order for Dr Reddy’s in US
20 Jun 2018 //
ECONOMIC TIMES
Indivior shares dive after Dr Reddy`s gets FDA approval for generic
16 Jun 2018 //
REUTERS
Reddy`s Laboratories gets USFDA nod for generic version of Suboxone
15 Jun 2018 //
ECONOMIC TIMES
Prezista® (Darunavir): Janssen Products v. Dr. Reddy`s Laboratories
24 May 2018 //
PATENT LITIGATION
How A Drugmaker Gamed The System To Keep Generic Competition Away
17 May 2018 //
NPR
Dr Reddy`s appoints Erez Israeli as COO and head of global generics biz
30 Apr 2018 //
BUSINESS-STANDARD
Lamotrigine : Dr. Reddy`s Laboratories v. Glaxosmithkline
13 Apr 2018 //
PATENT LITIGATION
Revlimid®(Lenalidomide) : Celgene Corporation v. Dr. Reddy`s Laboratories
12 Apr 2018 //
PATENT LITIGATION
Dr Reddy`s names ex-Teva official Erez Israeli as COO, global generics head
29 Mar 2018 //
BUSINESS-STANDARD
